The Senate Finance Committee grilled executives from seven major drugmakers on Tuesday.
Tuesday’s Senate Finance Committee hearing could produce fireworks over prices, R&D costs and executive compensation.
The recent declaration by President Donald Trump that taming unexpected medical bills would be a top priority for his administration echoed through the halls of Congress.
Key House and Senate committees kick off hearings on drug prices, and patients’ families weigh in with tragic stories.
Patients and doctors got a chance to share their nightmarish experiences with medical bills with President Donald Trump and other top White House officials.
Top House Republican also received more than $1 million from drugmakers since 2007.
En su libro de memorias, la ex primera dama relata la dolorosa experiencia que tuvieron que vivir con Barack Obama al perder un embarazo.
The attention may help women understand that miscarriage is common but still not easily talked about.
Though Rep. Tom MacArthur counts himself a moderate, many of his voters heading to the polls are furious about how he aided his party’s efforts to dismantle Obamacare.
Drugmakers’ contributions to lawmakers have peaked as surging drug prices emerge as a hot-button political issue. In the past decade, members of Congress have received nearly $79 million from 68 pharma PACs. And the giving crosses the aisle: In California, seven of the top 10 beneficiaries are Democrats — though Kevin McCarthy, the Republican House majority leader, tops other Golden State lawmakers in Congress by a wide margin.